INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Emulex Corp. in Connection with the Fairness of the Sale of the Company to Avago Technologies -- ELX

The following statement is being issued by Levi & Korsinsky, LLP:

TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED COMMON STOCK OF EMULEX CORP. (“Emulex” or “the Company”) PRIOR TO FEBRUARY 25, 2015 AND CONTINUE TO HOLD SUCH SHARES.

YOU ARE HEREBY NOTIFIED that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Emulex to Avago Technologies Limited. Click here to learn more about the investigation: http://zlk.9nl.com/emulexelx. There is no cost or obligation to you.

The Board of Directors of Emulex (NYSE: ELX) agreed to sell the Company to Avago Technologies Limited (Nasdaq: AVGO). Under the terms of the transaction, Emulex shareholders will receive $8.00 for each share of Emulex stock they own. The investigation concerns whether the Board of Emulex breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Avago Technologies Limited is underpaying for Emulex shares. Senior members of Emulex management and directors owning a combined 2.5 percent of Emulex’s outstanding shares have already agreed to tender their shares.

If you own Emulex common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/emulexelx.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.